These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9069543)

  • 1. Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes.
    Herrera-Insúa I; Pérez P; Martínez P; Gómez-Lus ML; Prieto J
    J Antimicrob Chemother; 1997 Feb; 39(2):223-8. PubMed ID: 9069543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of meropenem with humoral and phagocytic defences.
    Easmon CS
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():259-64. PubMed ID: 2681125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils.
    Pruul H; McDonald PJ
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):170-6. PubMed ID: 8508815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem.
    Adinolfi LE; Bonventre PF
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1012-8. PubMed ID: 3056244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal activity of imipenem in broth, serum and in the presence of human polymorphonuclear leukocytes against staphylococcus aureus and Klebsiella pneumoniae.
    Bassler M; Just HM; Gelbke H; Daschner F
    Eur J Clin Microbiol; 1984 Oct; 3(5):493-5. PubMed ID: 6389128
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis.
    White RL; Friedrich LV; Manduru M; Mihm LB; Bosso JA
    Diagn Microbiol Infect Dis; 2001 Jan; 39(1):39-47. PubMed ID: 11173190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postantibiotic sub-MIC effect of meropenem on Escherichia coli and Staphylococcus aureus.
    Martinez FF; Caminero MM; Izquierdo JI; Gomez-Lus Centelles ML; Prieto JP
    J Chemother; 1995 Nov; 7 Suppl 4():12-4. PubMed ID: 8904090
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo and in vitro study of several pharmacodynamic effects of meropenem.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Scand J Infect Dis; 1995; 27(5):469-74. PubMed ID: 8588137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The postantibiotic effect of meropenem and imipenem on selected bacteria.
    Nadler HL; Pitkin DH; Sheikh W
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity, post antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations.
    Bowker KE; Holt HA; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1996 Dec; 38(6):1055-60. PubMed ID: 9023653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vivo and in-vitro study of the postantibiotic effect of meropenem.
    Martín Caminero MM; Fuentes Martinez F; Izquierdo Izquierdo J; Gómez-Lus Centelles ML; Prieto Prieto J
    J Antimicrob Chemother; 1993 Dec; 32(6):917-8. PubMed ID: 8144441
    [No Abstract]   [Full Text] [Related]  

  • 13. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.
    Sumita Y; Fukasawa M
    J Antimicrob Chemother; 1995 Jul; 36(1):53-64. PubMed ID: 8537284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production.
    Sultan N; Cirak MY; Erbaş D
    Microbios; 2000; 103(405):97-106. PubMed ID: 11092191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of meropenem, against gram-positive bacteria.
    Kayser FH; Morenzoni G; Strässle A; Hadorn K
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
    Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
    J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influrence of recombinant human procalcitonin on phagocytic and candidacidal ability of polymorphonuclear leukocytes and on killing mechanisms of serum and blood aganist bacteria Staphylococcus aureus and Escherichia coli].
    Pincíková T; Bucová M; Slobodníková L
    Vnitr Lek; 2005 Dec; 51(12):1365-70. PubMed ID: 16430103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ciprofloxacin on the phagocytosis of Escherichia coli by human polymorphonuclear leukocytes].
    Pérez P; Herrera I; Martín M; Gómez-Lus ML; Prieto J
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):411-4. PubMed ID: 8260511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
    Bassler M; Blaschke H; Just M; Daschner FD
    Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of imipenem and meropenem on serum sensitivity and surface hydrophobicity of Klebsiella pneumoniae.
    Hostacká A
    Arzneimittelforschung; 1998 Nov; 48(11):1101-3. PubMed ID: 9850433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.